Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
Clinical trial NCT00929526 · COMPLETED
Trial details
- NCT number
- NCT00929526
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-02-01
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.